Reports
Global Clinical Diagnostics Market Share, Trends, Forecast: By Type: Molecular Diagnostics, Immunodiagnostics, Clinical Chemistry, Others; By Molecular Diagnostic Technology: Microarray/ DNA and Gene Chip, Next Generation Sequencing, Others; By Products; By Test Location; Regional Analysis; Competitive Landscape; 2024-2032
Global Clinical Diagnostics Market Outlook
The global clinical diagnostics market attained a value of more than USD 63.41 billion in 2021. The market is further expected to grow in the forecast period of 2024-2032 at a CAGR of around 6.73% to reach a value of over USD 93.75 billion by 2027.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The Clinical Diagnostics Industry in North America to Witness a Significant Growth in the Forecast Period
The market for clinical diagnostics in North America has been witnessing a robust growth due to an increase in awareness about health. Diagnostic tests help improve the patient care system and help reduce the overall cost by supporting the early detection of critical diseases, which is a major factor driving the market. The use of advanced diagnostic solutions in hospitals across the United States and Canada has been playing a crucial role in supporting the health of the citizens. Furthermore, with rising COVID-19 cases in the region, there has been an increased funding and a surge in the number of testing, which has boosted the overall market growth. Over the forecast period, the growing integration of AI and other technologies to improve patient care and improve existing services in healthcare facilities is expected to favour the market in the forecast period.
Clinical Diagnostics: Market Segmentation
The process of identifying a disease, condition, or injury based on the signs and symptoms in a patient by going through his health history and conducting a physical examination is known as clinical diagnosis. A diagnostic test is performed to identify the cause of symptoms or identify a disease and its risk factors.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The major types of clinical diagnostics are:
- Molecular Diagnostics
- Immunodiagnostics
- Clinical Chemistry
- Others
On the basis of molecular diagnostic technology, the market is categorised into:
- Microarray/ DNA and Gene Chip
- Next Generation Sequencing
- PCR Technology
- Others
Based on product, the clinical diagnostics industry is classified into:
- Instruments and Consumables
- Services
The market can be broadly categorised on the basis of test location into:
- Point of Care (POC)
- Self-Test or OTC
- Central Laboratories
The EMR report looks into the regional markets of clinical diagnostics like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Growing Demand for Advanced Diagnostic Solutions to Significantly Contribute Towards the Market Growth
Clinical diagnostics is used for managing patient’s health. It helps in monitoring the course of disease and one can identify the disease at an early stage. Additionally, it can help avoid long term complications among the infected patients, which is likely to enhance the importance of clinical diagnosis among the masses. Moreover, the increase in health awareness, coupled with the rising healthcare expenditure is aiding the market growth. Furthermore, the growing concerns pertaining to the risk of disease spread from infected patients are anticipated to boost the demand for clinical diagnostic kits in the forecast period. Diagnostic tests can be done either by instruments and consumables, or services. This factor is likely to enhance patient convenience, thereby aiding the market.
Key Industry Players in the Global Clinical Diagnostics Market
The report presents a detailed analysis of the following key players in the global clinical diagnostics market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Abbott Laboratories
- bioMérieux SA
- Bio-Rad Laboratories, Inc.
- Siemens AG
- QIAGEN GmbH
- Others
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, Molecular Diagnostic Technology, Products, Test Location, Region |
| Breakup by Type | Molecular Diagnostics, Immunodiagnostics, Clinical Chemistry, Others |
| Breakup by Molecular Diagnostic Technology | Microarray/ DNA and Gene Chip, Next Generation Sequencing, PCR Technology, Others |
| Breakup by Products | Instruments and Consumables, Services |
| Breakup by Test Location | Point of Care (POC), Self-Test or OTC, Central Laboratories |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratories, Inc., Siemens AG, QIAGEN GmbH, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Clinical Diagnostics Market Analysis
8.1 Key Industry Highlights
8.2 Global Clinical Diagnostics Historical Market (2018-2023)
8.3 Global Clinical Diagnostics Market Forecast (2024-2032)
8.4 Global Clinical Diagnostics Market by Type
8.4.1 Molecular Diagnostics
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.2 Immunodiagnostics
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.3 Clinical Chemistry
8.4.3.1 Historical Trend (2018-2023)
8.4.3.2 Forecast Trend (2024-2032)
8.4.4 Others
8.5 Global Clinical Diagnostics Market by Molecular Diagnostic Technology
8.5.1 Microarray/ DNA and Gene Chip
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Next Generation Sequencing
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.3 PCR Technology
8.5.3.1 Historical Trend (2018-2023)
8.5.3.2 Forecast Trend (2024-2032)
8.5.4 Others
8.6 Global Clinical Diagnostics Market by Products
8.6.1 Instruments and Consumables
8.6.1.1 Historical Trend (2018-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 Services
8.6.2.1 Historical Trend (2018-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.7 Global Clinical Diagnostics Market by Test Location
8.7.1 Point of Care (POC)
8.7.1.1 Historical Trend (2018-2023)
8.7.1.2 Forecast Trend (2024-2032)
8.7.2 Self-Test or OTC
8.7.2.1 Historical Trend (2018-2023)
8.7.2.2 Forecast Trend (2024-2032)
8.7.3 Central Laboratories
8.7.3.1 Historical Trend (2018-2023)
8.7.3.2 Forecast Trend (2024-2032)
8.8 Global Clinical Diagnostics Market by Region
8.8.1 North America
8.8.1.1 Historical Trend (2018-2023)
8.8.1.2 Forecast Trend (2024-2032)
8.8.2 Europe
8.8.2.1 Historical Trend (2018-2023)
8.8.2.2 Forecast Trend (2024-2032)
8.8.3 Asia Pacific
8.8.3.1 Historical Trend (2018-2023)
8.8.3.2 Forecast Trend (2024-2032)
8.8.4 Latin America
8.8.4.1 Historical Trend (2018-2023)
8.8.4.2 Forecast Trend (2024-2032)
8.8.5 Middle East and Africa
8.8.5.1 Historical Trend (2018-2023)
8.8.5.2 Forecast Trend (2024-2032)
9 North America Clinical Diagnostics Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe Clinical Diagnostics Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2018-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2018-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2018-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Clinical Diagnostics Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2018-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2018-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2018-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Historical Trend (2018-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Clinical Diagnostics Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2018-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2018-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Clinical Diagnostics Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2018-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2018-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 Abbott Laboratories
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 bioMérieux SA
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Bio-Rad Laboratories, Inc.
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Siemens AG
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 QIAGEN GmbH
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 Others
16 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Clinical Diagnostics Market: Key Industry Highlights, 2018 and 2032
2. Global Clinical Diagnostics Historical Market: Breakup by Type (USD Billion), 2018-2023
3. Global Clinical Diagnostics Market Forecast: Breakup by Type (USD Billion), 2024-2032
4. Global Clinical Diagnostics Historical Market: Breakup by Molecular Diagnostic Technology (USD Billion), 2018-2023
5. Global Clinical Diagnostics Market Forecast: Breakup by Molecular Diagnostic Technology (USD Billion), 2024-2032
6. Global Clinical Diagnostics Historical Market: Breakup by Products (USD Billion), 2018-2023
7. Global Clinical Diagnostics Market Forecast: Breakup by Products (USD Billion), 2024-2032
8. Global Clinical Diagnostics Historical Market: Breakup by Test Location (USD Billion), 2018-2023
9. Global Clinical Diagnostics Market Forecast: Breakup by Test Location (USD Billion), 2024-2032
10. Global Clinical Diagnostics Historical Market: Breakup by Region (USD Billion), 2018-2023
11. Global Clinical Diagnostics Market Forecast: Breakup by Region (USD Billion), 2024-2032
12. North America Clinical Diagnostics Historical Market: Breakup by Country (USD Billion), 2018-2023
13. North America Clinical Diagnostics Market Forecast: Breakup by Country (USD Billion), 2024-2032
14. Europe Clinical Diagnostics Historical Market: Breakup by Country (USD Billion), 2018-2023
15. Europe Clinical Diagnostics Market Forecast: Breakup by Country (USD Billion), 2024-2032
16. Asia Pacific Clinical Diagnostics Historical Market: Breakup by Country (USD Billion), 2018-2023
17. Asia Pacific Clinical Diagnostics Market Forecast: Breakup by Country (USD Billion), 2024-2032
18. Latin America Clinical Diagnostics Historical Market: Breakup by Country (USD Billion), 2018-2023
19. Latin America Clinical Diagnostics Market Forecast: Breakup by Country (USD Billion), 2024-2032
20. Middle East and Africa Clinical Diagnostics Historical Market: Breakup by Country (USD Billion), 2018-2023
21. Middle East and Africa Clinical Diagnostics Market Forecast: Breakup by Country (USD Billion), 2024-2032
22. Global Clinical Diagnostics Market Structure
Key Questions Answered in the Report
In 2021, the global clinical diagnostics market attained a value of more than USD 63.41 billion.
The market is projected to grow at a CAGR of around 6.73% between 2024 and 2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach a value of over USD 93.75 billion by 2027.
The major drivers of the industry such as the increasing health awareness, growing effectiveness of treatments, increasing demand for diagnostic tests for steady recovery of patients, increasing COVID-19 cases, and growing innovations in the healthcare industry are expected to aid the market growth.
The key market trends guiding the growth of the industry include the growing investments by key players in product marketing, coupled with the increasing R&D activities in research institutes.
The major regions in the industry are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The significant types of clinical diagnostics included in the market report are molecular diagnostics, immunodiagnostics, and clinical chemistry, among others.
The major molecular diagnostic technologies in the industry are microarray/ DNA and gene chip, next generation sequencing, and PCR technology, among others.
The various products based on which the market has been bifurcated are instruments and consumables, and services.
The different test locations of clinical diagnostics included in the market report are point of care (POC), self-test or OTC, and central laboratories.
The major players in the industry are Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratories, Inc., Siemens AG, and QIAGEN GmbH, among others.
Analyst Review
The global clinical diagnostics market attained a value of more than USD 63.41 billion in 2021, driven by the rising prevalence of chronic diseases, increasing geriatric population, and rising healthcare expenditure. Aided by the growing technological advancements in the healthcare industry, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of around 6.73%. The market is projected to reach a value of over USD 93.75 billion by 2027.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on type, the clinical diagnostics industry can be segmented into molecular diagnostics, immunodiagnostics, and clinical chemistry, among others. On the basis of molecular diagnostic technology, the market is classified as microarray/ DNA and gene chip, next generation sequencing, PCR technology, among others. Based on product, the market is broadly categorised into instruments and consumables, and services. On the basis of test location, the market is segmented into point of care (POC), self-test or OTC, and central laboratories. The major regional markets for clinical diagnostics are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratories, Inc., Siemens AG, and QIAGEN GmbH, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$2799
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER